Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Medical System Holdings Ltd.

en.cms.net.cn

Latest From China Medical System Holdings Ltd.

Sun's China, Japan Plans Gather Pace

Sun expects interleukin-23-targeting drugs to stay a preferred treatment option for psoriasis in the US and saw some sales uptick for its Ilumya in that market in Q2, although it isn’t keen on an auto injector option. Management was also upbeat on prospects in China and Japan.

Sales & Earnings Commercial

Sun Upbeat On IL-23 Prospects In US, Ilumya Faring ‘Reasonably’

Sun expects interleukin-23-targeting drugs to stay a preferred treatment option for psoriasis in the US and saw some sales uptick for its Ilumya in that market in Q2, although it isn’t keen on an auto injector option. Management was also upbeat on prospects in China and Japan.

Commercial Sales & Earnings

Sun Allies With AZ To Drive China Oncology Push

India's Sun Pharma joins hands with AstraZeneca to commercialize certain 'ready to use' oncology therapies in China, hoping to capitalize on the UK firm’s strong position in this market.
China Cancer

China's Hengrui Halts Most Generic Development

China’s favorite domestic drug maker seems to have a warning for the industry - innovate or halt. After the recent round of “4+7” centralized procurement saw some off-patent drugs priced at pennies, the leading Chinese firm Hengrui has decided to halve its generics portfolio to focus on innovative new drugs.

China Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • China Medical System Holdings Ltd.
  • Senior Management
  • Lam Kong, Chmn. & CEO
    Chen Yanling, CFO
    Chen Hongbing, COO
  • Contact Info
  • China Medical System Holdings Ltd.
    Phone: 755 82416868
    6F-8F, Block B, Majialong Chuangxin Bldg
    198 Daxin Rd.
    Nanshan District, Shenzhen,
    China
UsernamePublicRestriction

Register